Please select the option that best describes you:

Do synchronous or metachronous stage 1 or stage 2 colon cancer benefit from adjuvant chemotherapy?  

Without any high-risk features and with low MSI.



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Los Angeles VA Medical Center
I hear you, Dr. @Noelle K. LoConte, that's the con...
Sign in or Register to read more